A potential role of YC-I on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models

Thrombosis and Haemostasis

Volumn 93, Issue 5, 2005, Pages 940-948

  Pan, Shiow Lin ^a   Guh, Jin Hwa ^a   Peng, Chieh Yu ^a   Chang, Ya Ling ^a   Cheng, Fong Chi ^b   Chang, Jau Hsiang ^c   Kuo, Sheng Chu ^d   Lee, Fang Yu ^c   Teng, Che Ming ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b MDS Pharma Services   (Taiwan)

^c Yung Shin Pharmaceutical Industry Co Ltd   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Lipopolysaccharide; Nuclear factor B; YC I

Indexed keywords

1 BENZYL 3 (5 HYDROXYMETHYL 2 FURYL)INDAZOLE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CONCANAVALIN A; CYCLIC GMP; CYTOKINE; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DRUG MECHANISM; ENDOTOXEMIA; HUMAN; HUMAN CELL; INFLAMMATION; LUNG INJURY; MALE; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEPSIS; SURVIVAL RATE;

ANIMALS; BLOTTING, WESTERN; CYCLIC GMP; CYTOKINES; DISEASE MODELS, ANIMAL; DNA; ENDOTOXEMIA; HUMANS; IMMUNOHISTOCHEMISTRY; INDAZOLES; LEUKOCYTES; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LUNG; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PLATELET AGGREGATION INHIBITORS; RATS; RATS, WISTAR; SHOCK, SEPTIC; TIME FACTORS; UP-REGULATION;

EID: 18844366701     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH04-03-0195     Document Type: Article

References (32)

1. Stone R. Search for sepsis drugs goes on despite past failures. Science 1994; 264: 365-7.
2. Karima R, Matsumoto S, Higashi H, et al. The molecular pathogenesis of endotoxic shock and organ failure. Mol Med Today 1999; 5: 123-32.
3. Ortolani O, Conti A, De Gaudio AR, et al. The effect of glutathione and N-acetylcysteine on lipoperoxidative damage in patients with early septic shock. Am J Respir Crit Care Med 2000; 161: 1907-11.
4. Kox WJ, Volk T, Kox SN et al. Immunomodulatory therapies in sepsis. Intensive Care Med 2000; 26: S124-8.
5. Boyle WA 3rd, Parvathaneni LS, Bourlier V, et al. iNOS gene expression modulates microvascular responsiveness in endotoxin-challenged mice. Circ Res 2000; 87: E18-24.
6. Glauser MP. Pathophysiologic basis of sepsis: considerations for future strategies of intervention. Crit Care Med 2000; 28: S4-8.
7. Ochoa JB, Udekwu AO, Billiar TR, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991; 214: 621-6.
8. Nakayama DK, Geller DA, Lowenstein CJ, et al. Cytokines and lipopolysaccharide induce nitric oxide synthase in cultured rat pulmonary artery smooth muscle. Am J Respir Cell Mol Biol 1992; 7: 471-6.
9. Rees DD. Role of nitric oxide in the vascular dysfunction of septic shock. Biochem Soc Trans 1995; 23: 1025-9.
10. Szabo C. The role of peroxynitrite in the pathophysiology of shock, inflammation and ischemia-reperfusion injury. Shock 1996; 6: 79-88.
11. Berner F, Niemeyer CM, Leititis JU, et al. Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-alpha, interleukin (IL)-1beta, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis. Pediatr Res 1999; 44: 469-77.
12. Hack CE, Aarden LA, Thijs LG. Role of cytokines in sepsis. Adv Immunol 1997; 66: 101-95.
13. Oberholzer A, Oberholzer C, Moldawer LL. Interleukin-10: a complex role in the pathogenesis of sepsis syndromes and its potential as an anti-inflammatory drug. Crit Care Med 2002; 30: S58-63.
14. Dinarello CA. Anti-cytokine therapies in response to systemic infection. J Investig Dermatol Symp Proc 2001; 6: 244-50.
15. Blackwell TS, Christman JW. The role of nuclear factor-κB in cytokine gene regulation. Am J Respir Cell Mol Biol 1997; 17: 3-9.
16. Ko FN, Wu CC, Kuo SC, et al. YC-1, a novel activator of platelet guanylate cyclase. Blood 1994; 84: 4226-33.
17. Friebe A, Schultz G, Koesling, a Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. EMBO J 1996; 15: 6863-8.
18. Pan SL, Guh JH, Huang YW, et al. Inhibition of ras-mediated cell proliferation by benzyloxybenzaldehyde. J Biomed Sci 2002; 9: 622-30.
19. Hanada T, Yoshimura A. Regulation of cytokine signalling and inflammation. Cytokine Growth Factor Rev 2002; 13: 413-21.
20. Taniguchi T, Koido Y, Aiboshi J, et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27: 1262-4.
21. Kasai T, Inada K, Takakuwa T, et al. Anti-inflammatory cytokine levels in patients with septic shock. Mol Pathol Pharmacol 1997; 98: 34-42.
22. Furie MB, Randolph GJ. Chemokines and tissue injury. Am J Pathol 1995; 146: 1287-301.
23. Ng PC, Li K, Wong RP, et al. Proinflammatory and anti-inflammatory cytokine responses in preterm infants with systemic infections. Arch Dis Child Fetal Neonatal Ed 2003; 88: F209-13.
24. Taniguchi T, Koido Y, Aiboshi J, et al. Change in the ratio of interleukin-6 to interleukin-10 predicts a poor outcome in patients with systemic inflammatory response syndrome. Crit Care Med 1999; 27: 1262-4.
25. Marshall JC. Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2003; 2: 391-405.
26. Rothermund L, Friebe A, Paul M, et al. Acute blood pressure effects of YC-1-induced activation of soluble guanylyl cyclase in normotensive and hypertensive rats. Br J Pharmacol 2000; 130: 205-8.
27. Conkling PR, Greenberg CS, Weinberg JB. Tumor necrosis factor induces tissue factor-like activity in human leukemia cell line U937 and peripheral blood monocytes. Blood 1998; 72: 128-33.
28. Bevilacqua MP, Pober JS, Majeau GR, et al. Recombinant tumor necrosis induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 12: 4533-7.
29. Gregory SA, Morrissey JH, Edgington TS. Regulation of tissue factor gene expression in the monocyte procoagulant response to endotoxin. Mol Cell Biol 1989; 9: 2752-5.
30. Teng CM, Wu CC, Ko FN, et al. YC-1, a nitric oxide-independent activator of soluble guanylate cyclase, inhibits platelet-rich thrombosis in mice. Eur J Pharmacol 1995; 320: 161-6.
31. Cauwels A, Van Molle W, Janssen B et al. Protection against TNF-induced lethal shock by soluble guanylate cyclase inhibition requires functional inducible nitric oxide synthase. Immunity 2000; 13: 223-31.
32. Wang JP, Chang LC, Raung SL, et al. Inhibition of superoxide anion generation by YC-1 in rat neutrophils through cyclic GMP-dependent and -independent mechanisms. Biochem Pharmacol 2002; 63: 577-85.